Middletown, DE -- (SBWIRE) -- 08/20/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Danone SA (ADR)(OTCMKTS:DANOY), Industrial & Comm.Bank of China Ltd(ADR)(OTCMKTS:IDCBY), BASF SE (ADR)(OTCMKTS:BASFY), Generex Biotechnology Corporation(OTCMKTS:GNBT).
Danone SA (ADR)(OTCMKTS:DANOY) ended lower -0.88% and complete the day at $15.71. The total number of shares changed hands during the day was 101,791. After opening at $15.71, the stock hit as high as $15.75. However, it traded between $11.78 and $16.12 over the last twelve months.
Danone SA is a France-based food company that primarily produces fresh milk products, baby foods, biscuits, cereal products and medical nutrition products.
Has DANOY Found The Bottom and Ready To Move Up? Find Out Here
Industrial & Comm.Bank of China Ltd(ADR)(OTCMKTS:IDCBY) closed yesterday at $13.56. Around 88.02k shares were traded. The company is now valued at around $ 237.06 billion.
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED (ICBC) is involved in the provision of banking and related financial services
How Should Investors Trade IDCBY Now? Don’t Miss out a Special Trend Analysis
BASF SE (ADR)(OTCMKTS:BASFY) moved -0.77 percent lower at $90.15 and traded between $90.14 and $91.20 after opening the day at $91.15. Its performance over the last five days remained 2.32%, which stands at -1.96% for a month. Going back further than one month, 1-year performance after recent close was -5.11%.
BASF SE is a German chemical company. It diversifies its activities into five business segments: Chemicals, providing basic products and specialties including nitric acid and methanol, basic chemicals including ethylene and butadiene and intermediates, among others; Performance Products, providing products for the coatings and paints industry
Why Should Investors Buy BASFY After the Recent Fall? Just Go Here and Find Out
Generex Biotechnology Corporation(OTCMKTS:GNBT) shares fall, losing -4.62 percent to close at $0.0351. The stock is up around 40.4% this year and -54.42% for the last 12 months. Around 3.45 million shares changed hands yesterday, lower from an-average trading volume of 3.72 million shares.
Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Will GNBT Get Buyers Even After The Recent Rally?Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)